Ora Banda Mining Ltd (ASX:OBM) has successfully completed the retail component of a 4-for-13 accelerated non-renounceable pro-rata entitlement offer, which completes its A$20 million equity fundraising.
The retail entitlement offer closed on March 17, 2022, pursuant to which Ora Banda will issue around 144.9 million new shares at A$0.05 per new share, to raise about A$7.25 million before costs.
Futura Medical has had a price target of 102p or five times the current market price reiterated by broker Liberum after the commercialisation deal for MED3000 with Menarini announced today.
Specifically, Menarini’s South Korea subsidiary will assume responsibility for the approval and marketing of MED3000 in this geography.
Chariot Ltd (AIM:CHAR, OTC:OIGLF) is set for ‘significant progress on several fronts’ and has potential to add material shareholder value, according to stockbroker Peel Hunt.
Repeating a ‘buy’ rating the broker followed up Chariot’s announcement, on Monday, that it had entered into a partnership to advance a renewable energy project for a mining operation in Zambia.
The Royal Mint said it will introduce the use of recycled gold to its exchange-traded commodity (ETC), under a partnership with Quintet Private Bank.
The Royal Mint Physical Gold ETC (LSE:RMAU), which is already listed on the London Stock Exchange, will then be backed, in part, by bars made from recycled gold, making it the world’s first gold ETC or exchange-traded fund to be backed by recycled gold bars, according to research conducted by HANetf.
Futura Medical PLC (AIM:FUM, OTC:FAMDF) has inked an exclusive licensing deal for its erectile dysfunction (ED) gel covering South Korea.
It is teaming up with the local subsidiary of Menarini Group, a large Italian biopharma business.
Arecor Therapeutics PLC (AIM:AREC) said its proprietary insulin products, AT247 and AT278, have been granted a patent by the United States Patent and Trademark Office.
Patent US 11278624 will protect the novel formulations of the products, which chief scientific officer Dr Jan Jezek explained are based on a combination of existing insulin analogues and the company’s innovative formulation science.
88 Energy Ltd (AIM:88E, ASX:88E, OTC:EEENF) has completed drilling of the Merlin-2 well in Alaska after reaching its target depth of 7,334 feet.
All three target reservoirs - Nanushuk 20 (N20), N19 and N18 - were penetrated with elevated gas readings while cutting samples revealed oil shows in all target intervals, said a statement.
United Oil & Gas Plc told investors it has reached a settlement agreement with Anasuria Hibiscus UK Ltd in relation to the Crown field disposal milestone payment. The agreement sees the AIM-quoted company receive US$2.5mln across three instalments.
In a stock market statement, the company said it brings an end to the matter and no further amounts will be due to United from AHUK in connection with the sale of Licence P2366.